Schall, Brown & Schwartz LLP Files Class Action Against Beta Bionics, Inc
News related to:Beta Bionics, Inc · 2 min read
LOS ANGELES, Oct. 12, 2026 /CourierPR/ -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, has filed a federal securities class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) on behalf of investors who purchased the company's common stock between July 30, 2025, and February 24, 2026, inclusive. The lawsuit, titled Holtzman v. Beta Bionics, Inc. et al., No. 2:26-cv-09999 (C.D Cal.), alleges that the company and certain top executive officers violated the Securities Exchange Act of 1934.
According to the complaint, Beta Bionics made false and misleading statements to the market about its automated insulin delivery system, known as the iLet Bionic Pancreas insulin pump. Throughout the Class Period, the company and its executives touted the safety, efficacy, and commercial success of the iLet. However, after the FDA issued a Form 483 following an inspection of the company's manufacturing facility, the executives repeatedly assured investors that the agency's observations concerned only the company's criteria for deciding which customer complaints were reportable, and that they reflected no underlying problem with the device.
In reality, the FDA's findings reached the company's quality management system, its investigation and correction of known device malfunctions, and the risk analysis for the device itself. The unreported events included serious injuries, which the company had failed to disclose. Despite this, the executives continued to reassure investors and characterized the agency's concerns as procedural. As the truth emerged, the price of Beta Bionics common stock declined, resulting in significant losses for investors.
Beta Bionics investors have until November 3, 2026, to seek appointment as lead plaintiff of the purported class in the lawsuit. Shareholders who purchased shares of BBNX during the Class Period are encouraged to contact Schall, Brown & Schwartz LLP at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or by phone at 310-301-3335, to discuss their rights and potential compensation. The firm's website, www.schallfirm.com, also provides contact information.
Schall, Brown & Schwartz LLP, known for its expertise in securities class action lawsuits and shareholder rights litigation, represents investors around the world. The firm has a track record of recovering over a billion dollars for violations of securities laws and corporate misfeasance.